Baxter (BAX) Misses Q2 EPS by 5c; Offers Guidance

Baxter (NYSE: BAX) reported Q2 EPS of $0.55, $0.05 worse than the analyst estimate of $0.60. Revenue for the quarter came in at $3.71 billion versus the consensus estimate of $3.79 billion.

GUIDANCE:

Baxter sees Q3 2023 EPS of $2.92-$3.00, versus the consensus of $2.93.

For earnings history and earnings-related data on Baxter (BAX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings